Colin Raffel , currently an Associate Professor at the University of Toronto and Associate Research Director at the Vector Institute , is a leading researcher in machine learning and natural language processing . His career spans roles at Hugging Face (Faculty Researcher), Google Brain (Senior Research Scientist), and UNC Chapel Hill (Assistant Professor). Education: PhD in Electrical Engineering (Columbia), MA in Music/Science (Stanford), BA in Mathematics (Oberlin) Key affiliations: Google Brain (2016-2020), Hugging Face (2021-present), Vector Institute (2023-present) His research focuses on language model development , attention mechanisms , efficient machine learning , and music information retrieval . Recent work explores model merging , parameter-efficient fine-tuning , and data-constrained language models . Teaching : Has instructed courses at University of Toronto and UNC Chapel Hill on Neural Networks , Deep Learning , and Information Theory . Academic service includes organizing ICLR workshops and serving as Senior Area Chair for NeurIPS and EMNLP . Notable awards : NSF CAREER (2022), Caspar Bowden Award (2023), NeurIPS Outstanding Paper (2023) Key contributions : Core developer of WT5 , Git-Theta , and mir_eval software
Dr. Carolyn Emery is a Professor in the Faculty of Kinesiology at the University of Calgary, with joint appointments in Pediatrics and Community Health Sciences at the Cumming School of Medicine. She holds leadership roles as Chair of the Sport Injury Prevention Research Centre (an International Olympic Committee Research Centre) and the Alberta Children’s Hospital Research Institute. Her affiliations include the McCaig Institute for Bone and Joint Health, Hotchkiss Brain Institute, and O’Brien Institute for Public Health. Dr. Emery’s education includes a BScPT from Queen’s University (1988), MSc in Epidemiology from the University of Calgary (1999), and PhD in Epidemiology from the University of Alberta (2004). Her research focuses on injury prevention in youth sports, concussion, and pediatric rehabilitation, aiming to reduce long-term health consequences such as osteoarthritis and post-concussion syndrome. She leads major grants including CIHR’s “SHRed Injuries” and NFL-funded concussion surveillance programs. Her research interests emphasize practical interventions for injury prevention, including neuromuscular training and policy changes. Recent work explores concussion outcomes in adolescents, biomechanical injury mechanisms, and global sport safety initiatives. She has published extensively on topics like sport-related musculoskeletal injuries, concussion management, and the epidemiology of youth sports. Dr. Emery has received over 20 awards, including the Royal Society of Canada Fellowship, Killam Professorship, and CIHR Canada Research Chair. Her work bridges clinical practice, policy, and community engagement to enhance public health outcomes in sports and youth recreation. Her lab, the Sport Injury Prevention Research Centre, collaborates internationally to develop evidence-based strategies for injury prevention. Current projects include evaluating the impact of tackle laws in rugby, head acceleration in wrestling, and long-term consequences of pediatric concussions.
Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.
Claire Célérier is an Associate Professor of Finance at the Rotman School of Management, University of Toronto, where she holds the Canada Research Chair in Household Finance. Her academic career spans prestigious institutions including the University of Toronto (where she advanced from Assistant to Associate Professor between 2016-2022) and the University of Zurich (2014-2016). She maintains an affiliation with the People's History Lab and actively contributes to academic discourse through conference organization including 'Race, Equity and Public Policy' (2023) and 'Banks, States and the People' (2024). Dr. Célérier's research explores how finance can benefit households through multiple lenses including behavioral economics, asset pricing, and financial history. Her work investigates innovation in finance, diversity and inclusion impacts, and historical perspectives on financial systems. She has developed significant expertise in household finance, banking, and the intersection of finance with social issues, particularly racial disparities in financial markets as demonstrated in her award-winning research on the Freedman's Savings Bank. Her scholarly output shows a clear trajectory from foundational work on security design and investor behavior toward increasingly socially relevant research on financial inclusion, racial equity, and household financial decision-making. Recent publications demonstrate her growing focus on historical contexts of financial systems and their contemporary implications, particularly regarding marginalized communities. Canada Research Chair in Household Finance (2024) Bank of Canada Governor's Award (2022) University of Toronto Top 5% Merit Award (2021) Petro Canada Young Innovators Award Program (2021) Multiple Rotman School of Management Teaching Awards (2019-2021) Ieke van den Burg Prize for Research on Systemic Risk (2015) Dr. Célérier has successfully secured substantial research funding including Insight Development Grants (CAD 54,500), Connaught Research Grant (CAD 10,000), and the Marianne and Marcus Wallenberg Foundation Grant (EUR 400,000). She mentors several PhD students including Andrada Bilan (2020), Alexey Vasilenko (2023), and Purnoor Tak (Expected 2026), and has supervised numerous master's theses at both University of Toronto and University of Zurich. Her service contributions include Rotman School of Management MBA program committee, executive committee, seminar coordination, and faculty recruiting committee.
Adrien Desjardins is a Professor at the University of British Columbia, jointly appointed in the Department of Mechanical Engineering and Department of Electrical and Computer Engineering within the Faculty of Applied Science. He joined UBC in 2024 after serving as a Full Professor at University College London from 2019-2024, following 13 years on faculty there. His educational background includes a B.Sc. from UBC (2001) and a Ph.D. from MIT and Harvard University (2007). Dr. Desjardins' research program focuses on interdisciplinary development of imaging and sensing modalities and autonomous robotics with marine and biomedical applications. His work integrates photonics, ultrasound, machine learning, and robotics to create innovative diagnostic tools and sensing systems, particularly in optical coherence tomography, diffuse optical spectroscopy, and photoacoustic imaging. His publication record reveals an evolution from foundational neuroimaging work (2001) toward increasingly sophisticated optical systems culminating in breakthroughs like ultrasensitive optical microresonators for ultrasound sensing (2017), demonstrating consistent innovation in biomedical optics with growing emphasis on machine learning integration and real-world applications. His scientific contributions have been recognized through prestigious awards: Research Chair from the Royal Academy of Engineering Healthcare Technologies Challenge Award from EPSRC Starting grants from ERC, EPSRC, and Royal Society World Economic Forum Young Scientist (2015) UCL Provost Teaching Prize (2013) Dr. Desjardins actively mentors graduate students and secures major research funding through competitive grants, with current openings for January/September 2025 intakes. His program involves close industry collaboration indicating strong translational focus, though specific lab names aren't mentioned. The interdisciplinary nature of his work suggests teams spanning engineering, computer science, and medical disciplines working on next-generation imaging systems for healthcare and marine exploration.
Dr. Shyh-Dar Li is a Professor and Tong Louie Chair in Pharmaceutical Sciences at the University of British Columbia's Faculty of Pharmaceutical Sciences, where he also serves as Chair of Nanomedicine and Chemical Biology. With a BSc in pharmacy from National Taiwan University (1998) and PhD in pharmaceutical sciences from UNC Chapel Hill (2008), followed by postdoctoral training at UC San Diego's Moores Cancer Center (2009), Dr. Li has established himself as a leading researcher in advanced drug delivery systems. His research focuses on developing innovative nanomedicine platforms for targeted delivery of biological therapeutics including peptides, proteins, antibodies, and nucleic acids. Dr. Li's laboratory has pioneered several novel drug delivery approaches, particularly in lipid-based nanoparticles, phospholipid-free vesicles, and polymer systems for cancer immunotherapy, pain management, and protein delivery. His work bridges fundamental nanotechnology with translational applications for difficult-to-treat diseases. Analysis of his recent publications reveals a strong emphasis on tumor microenvironment modulation, endosomal escape mechanisms for nucleic acid delivery, and non-invasive delivery routes for protein therapeutics. His research demonstrates increasing sophistication in nanocarrier engineering, with recent work incorporating machine learning approaches to optimize nanoparticle design and expanding into immunomodulatory therapies that harness the body's immune system to fight cancer. Scientific Recognition: 2014 AFPC New Investigator Award 2013 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies 2013 CIHR New Investigator Award 2013 CSPS Early Career Award 2012 Prostate Cancer Foundation Young Investigator Award Dr. Li's research program has been consistently supported by major Canadian funding agencies including CIHR, NSERC, and MITACS. He actively collaborates across disciplines and accepts graduate students into his research program, focusing on cutting-edge approaches to overcome biological barriers in drug delivery. His laboratory, the Laboratory of Targeted Drug Delivery and Nanomedicine, serves as a hub for innovation in pharmaceutical nanotechnology.
Thibault Mayor is a Professor in the Department of Biochemistry and Molecular Biology and the Michael Smith Laboratories at the University of British Columbia (Vancouver). His research focuses on understanding how cells manage misfolded proteins, with implications for neurodegenerative diseases like Parkinson's and Alzheimer's. He holds academic affiliations with the Centre for High-Throughput Biology (CHiBi) and has been recognized with awards including the UBC Killam Teaching Award (2020). Education: BSc, University of Geneva, Switzerland (1997) PhD, University of Geneva & Max Planck Institute of Biochemistry, Germany (2001) Postdoctoral Fellow, California Institute of Technology (2002) Research Interests: Mayor's lab investigates protein homeostasis, ubiquitin-proteasome system dynamics, and the molecular mechanisms underlying protein aggregation in aging and disease. Projects include proteomic approaches to identify aggregation-prone proteins and develop microbial cell factories for protein production. Grants & Awards: CIHR Project Grant ($730K, 2018) Michael Smith Foundation Career Award (2012) UBC Killam Teaching Award (2020) Labs & Collaborations: The Mayor Lab is part of the Michael Smith Laboratories and collaborates with computational biologists like Jörg Gsponer. They maintain active partnerships in proteomics and systems biology, contributing to initiatives like the BC Proteomics Network.
Dr. Xiaoxiao Li is an Assistant Professor in the Electrical and Computer Engineering Department at the University of British Columbia (UBC), with joint appointments in Computer Science (Associate Member) and the School of Medicine at Yale University (Adjunct Assistant Professor). She is also a Canada CIFAR AI Chair and Canada Research Chair (Tier II) in Responsible AI. Her research focuses on enhancing trustworthiness, fairness, and efficiency in AI algorithms and foundation models, particularly in healthcare applications. Education: B.S. (Honors) in Zhejiang University (2015), Ph.D. in Biomedical Engineering from Yale University (2020), Postdoc at Princeton University (2020-2021). She leads the Trusted and Efficient AI (TEA) Lab at UBC, which develops algorithms for federated learning, medical imaging analysis, and interpretable AI systems. Research interests include federated learning, generative models, medical image analysis, AI fairness, and graph-based methods for neuroimaging. Recent projects include GMValuator (data valuation for generative models), FairMedFM (fairness benchmarking in medical AI), and FedTextGrad (textual gradient-based FL optimization). Grants: Canada Foundation for Innovation Grant (2023), UBC Green Lab Fund (2023), Vector Institute funding Teaching: Courses on machine learning, federated learning, and AI ethics at UBC Awards & Recognition: Best Paper Award at FL@FM WWW 2024, Editorial Board Member of Medical Image Analysis , multiple top-tier conference acceptances (NeurIPS, ICLR, CVPR, MICCAI). Lab & Teams: TEA Lab collaborates with industry and hospitals to translate AI research into clinical tools. Current projects address AI fairness in healthcare, federated learning for medical data, and multimodal medical analytics.
David Vocadlo is a Distinguished Professor of Chemistry and Molecular Biology & Biochemistry at Simon Fraser University (SFU), holding the Canada Research Chair in Chemical Biology. His research focuses on Chemical Glycobiology, investigating carbohydrate-processing enzymes and developing chemical tools to study glycan roles in health and disease. His lab explores O-GlcNAc signaling, neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s), and enzyme inhibitors for therapeutic applications. Education: PhD from University of British Columbia (UBC), followed by a CIHR postdoctoral fellowship at UC Berkeley. Key roles include E.W.R. Steacie Memorial Fellow and Royal Society Fellow. Research highlights include O-GlcNAcase inhibitors for neuroprotection, glycan structure-function relationships, and enzyme activity imaging tools. Collaborates globally with experts in glycobiology and employs cutting-edge techniques like chemical synthesis, mass spectrometry, and live-cell imaging. Awards: Distinguished Professor title, Canada Research Chair, Royal Society Fellowship. Active in training researchers through SFU’s graduate programs, emphasizing interdisciplinary approaches. Lab members work on topics ranging from enzyme mechanisms to disease modeling.
Arash Arami is an Associate Professor in the Department of Mechanical and Mechatronics Engineering at the University of Waterloo, cross-appointed in Systems Design Engineering. He directs the Neuromechanics and Assistive Robotics Laboratory and maintains affiliations with Waterloo Robohub, the Centre for Bioengineering and Biotechnology, Waterloo AI institute, and KITE institute at Toronto Rehab Institute. He earned his Doctorate in Electrical Engineering from EPFL (2014), Master of Science from University of Tehran (2009), and Bachelor of Science from University of Tabriz (2006), all in Control Engineering. His research in Assistive Robotics and Rehabilitation Engineering integrates Machine Learning with Neuromechanics to develop intelligent systems for human movement analysis. Key focus areas include exoskeleton control algorithms, wearable sensor systems, and neural control modeling for rehabilitation applications. Recent publications demonstrate interdisciplinary work spanning robotics, biomedical engineering, and materials science, with emphasis on real-time human locomotion prediction, exoskeleton-human interaction, and data-driven health monitoring solutions. Dr. Arami serves as Chair of the NSERC Scholarship Committee (2021-2023) and mentors graduate students through the Mechatronics Exchange Study program. His teaching includes core courses in control systems, robot manipulators, and biomechanical engineering. The Neuromechanics and Assistive Robotics Laboratory fosters collaborations with clinical partners at Toronto Rehab Institute, focusing on translating robotic innovations into practical rehabilitation tools through interdisciplinary teamwork.
Professor Hassan Rivaz is a Full Professor and Concordia University Research Chair in Medical Imaging with Deep Learning at Concordia University's Gina Cody School of Engineering and Computer Science. He holds appointments in the Department of Electrical and Computer Engineering and is cross-appointed to the Department of Computer Science & Software Engineering. Dr. Rivaz serves as the Founding Director of the IMPACT Lab and actively supervises PhD students in Electrical and Computer Engineering and Computer Science programs. Dr. Rivaz received his PhD from Johns Hopkins University in 2011, Master's degree from the University of British Columbia, and Bachelor's degree from Sharif University, followed by postdoctoral training at McGill University. His academic journey includes prestigious awards such as the NSERC Post-Doctoral Fellowship and Jeanne Timmins Costello Post-Doctoral Award. His research focuses on advancing medical image analysis through deep learning techniques, particularly in ultrasound imaging applications. Dr. Rivaz has made significant contributions to quantitative ultrasound, cancer detection, lymphedema assessment, and ultrasound elastography. His work bridges theoretical algorithm development with practical clinical applications, addressing challenges in medical image denoising, segmentation, registration, and tissue characterization. The IMPACT Lab under his direction develops innovative solutions for medical imaging problems with direct clinical relevance. Analysis of his recent publications reveals a strong emphasis on deep learning applications for ultrasound image processing, with particular focus on denoising techniques, elastography improvements, and segmentation algorithms. His work consistently addresses the challenge of working with real clinical data rather than simulated environments, contributing to more practical medical imaging solutions. Dr. Rivaz has received numerous prestigious awards including: Concordia University Research Chair in Medical Imaging with Deep Learning (2023–2028) QBIN/RBIQ Rising Star in Bio-Imaging in Quebec (2022) Concordia University Research Chair in Medical Image Analysis (2018-2023) Petro-Canada Young Innovator Award (2016–2018) He actively mentors graduate students, with many recipients of competitive scholarships including NSERC CGS, FRQNT, and FRQS awards. Dr. Rivaz serves on editorial boards for top journals including IEEE Transactions on Medical Imaging (since 2017), Medical Image Analysis (since 2025), and IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control (since 2018). He has organized major conferences including IEEE EMBC 2020, ISBI 2021, and IEEE IUS 2023, and served as Area Chair for MICCAI from 2017 to 2024. As Founding Director of the IMPACT Lab, Dr. Rivaz leads a multidisciplinary research team focused on innovative medical imaging solutions. The lab maintains strong collaborations with hospitals and research institutions to translate imaging technologies into clinical practice. Current projects include developing AI-powered ultrasound analysis tools, quantitative imaging biomarkers for cancer diagnosis, and advanced techniques for ultrasound elastography with applications in tissue characterization and disease detection.
Sachdev Sidhu is a Research Professor and Entrepreneur in Residence at the University of Waterloo. His research focuses on synthetic antibodies, protein engineering, and biotechnological applications. He leads efforts in developing novel therapeutic antibodies, engineered protein systems, and molecular tools for biomedical research. His work spans cancer therapy, viral infection countermeasures, and regenerative medicine. Sidhu is also involved in translational research, bridging academic discoveries with commercial applications through entrepreneurial ventures. Key research interests include synthetic antibody libraries, CAR T-cell engineering, ubiquitin-based therapeutics, and phage display technologies. He has contributed to advancements in targeted therapies for glioblastoma, leukemia, and ocular diseases. His team develops innovative methods for protein design, such as engineered ubiquitin variants and modular antibody architectures. Publications highlight breakthroughs in antibody-based treatments, including synNotch CAR T cells for glioblastoma and neutralizing antibodies against SARS-CoV-2. His work integrates structural biology, molecular biology, and computational approaches to address complex biomedical challenges. Sidhu collaborates with industry partners to advance technologies into clinical and commercial settings.
Dr. Frances Chen is a Professor and Area Coordinator in the Department of Psychology at the University of British Columbia (UBC), located on the traditional, ancestral, and unceded territory of the Musqueam People. She holds a PhD from Stanford University (2009). Her research integrates health psychology, social psychology, and neuroendocrinology to explore how social experiences influence mental and physical health. Key areas include the physiological impacts of loneliness, social support, and hormonal changes during puberty on adolescent development. Education: PhD, Psychology, Stanford University, 2009 Research Focus: Dr. Chen investigates how social interactions 'get under the skin' through studies on loneliness, stress, conflict negotiation, and hormonal mechanisms. Her work emphasizes interventions to enhance social connection and reduce health disparities. Recent Article Trends: Recent publications highlight interdisciplinary approaches, including genetic influences on depression, effects of near-infrared lighting on cognition, and longitudinal studies on adolescent hormonal contraceptive use. Her work bridges basic science and applied health outcomes. Awards & Grants: Michael Smith Health Research BC C2 Award (2022) Killam Faculty Research Fellowship (2019) Teaching & Learning Enhancement Fund Grant (2025) SSHRC Prosociality Project Funding (2023) Lab & Mentorship: Director of the Social Health Lab, she mentors graduate and undergraduate students, prioritizing equity and inclusion. Recent lab achievements include studies on teen health development and interventions to improve student success in psychology programs. Lab Initiatives: UBC Teen Health and Development Study (longitudinal hormonal/mental health tracking) NIR lighting health impact research (collaborative interdisciplinary project) Prosociality 'in the Wild' SSHRC project
Professor Peter F. Driessen is a faculty member in the Department of Electrical and Computer Engineering at the University of Victoria, with a cross-appointment in the School of Music. He holds a BSc and PhD from the University of Victoria and is a Professional Engineer (PEng). His research focuses on communication systems, signal processing, control, and interdisciplinary projects in computer music and wireless technologies. Key areas include audio/video signal processing, radio propagation, sound recording, and multimedia systems. He leads the University of Victoria Propagation Laboratory, which explores radio wave propagation and Amateur radio integration with engineering education. His work spans theoretical research and applied projects like ECOSat satellite systems, software-defined radio (SDR), and innovative musical instruments such as the Radio Drum. He supervises undergraduate and graduate projects in these domains through ELEC 499 courses. Notable contributions include the APEGBC Editorial Board Award for Best Paper (2002) and patents in wireless networking and signal processing. His teaching includes courses in signal analysis and electromagnetics, and he collaborates on interdisciplinary programs like the Music/Computer Science degree. Education: BSc in Electrical Engineering, University of Victoria PhD in Electrical Engineering, University of Victoria Research Interests: Audio and video signal processing for music and media Software-defined radio and Amateur radio technologies Satellite communication and ground station development Gesture-based interfaces and musical instrument design Error mitigation in streaming audio/video Optical and microwave-photonic systems Labs & Collaborations: Propagation Laboratory (radio wave research) UVic Experimental Radio Group (Amateur radio club) UVic Satellite Design Team (ECOSat projects) UVic Centre for Aerospace Research Grants & Awards: APEGBC Editorial Board Award (2002) Multiple US patents in wireless systems and signal processing
Milos Popovic is a Professor and Director at the Institute of Biomedical Engineering, University of Toronto, and serves as Senior Scientist and Director of Research at the Toronto Rehabilitation Institute (KITE), University Health Network. He holds the Toronto Rehab Chair in Spinal Cord Injury Research and Neural Engineering and co-leads the Centre for Research in Advanced Neural Implant Applications (CRANIA). His leadership spans academic, clinical, and translational research domains in neuroengineering and rehabilitation. His research focuses on neurorehabilitation, neuroprosthetics, functional electrical stimulation (FES), brain-machine interfaces, and assistive technologies . He develops physiological control systems and therapeutic robotics to restore motor function after spinal cord injury and stroke. His work integrates biomechanics, signal processing, and human-machine interfaces to innovate rehabilitative solutions. Dr. Popovic's recent publications emphasize electrical neuromodulation, FES therapy for motor recovery, deep brain stimulation for cognitive deficits, and wearable/implantable technologies . The articles reflect a strong trend toward closed-loop systems, translational research, and interdisciplinary innovation in neuroengineering and rehabilitation. Swiss National Science Foundation Technology Transfer Award - 1st place (1997) Engineering Medal for Research and Development, Professional Engineers of Ontario (2008) Elected to the College of Fellows, American Institute of Medical and Biological Engineering (2011) 1st Prize and Best Intellectual Property Award, TiEQuest Business Venture Competition (2012) Morris (Mickey) Milner Award for Assistive Technologies (2013) University of Toronto Inventor of the Year Award (2013) University Health Network’s Inventor of the Year Award (2015) Dr. Popovic has secured significant research funding and leads the Neural Engineering and Therapeutics team at KITE. He co-founded MyndTec Inc. and the Canadian National Spinal Cord Injury Conference, demonstrating strong mentorship, innovation, and national impact. He advises graduate students and postdoctoral fellows in biomedical engineering and rehabilitation sciences. He leads the Rehabilitation Engineering Laboratory and the Neural Engineering and Therapeutics Team at KITE, fostering collaboration across engineering, neuroscience, and clinical rehabilitation. His lab develops advanced neurotechnologies with a focus on clinical translation and commercialization.
